About: What do surgeons need to know about the digestive disorders and paraclinical abnormalities induced by COVID-19?

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: What do surgeons need to know about the digestive disorders and paraclinical abnormalities induced by COVID-19? Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	What do surgeons need to know about the digestive disorders and paraclinical abnormalities induced by COVID-19?
Creator	Gornet, Jean-Marc Minh, Tran Hassid, Deborah Leleu, Florian Linh, My Tran, My
Source	Elsevier; Medline; PMC; WHO
abstract	Abstract The symptoms associated with COVID-19 are mainly characterized by a triad composed of fever, dry cough and dyspnea. However, digestive symptoms have also been reported; at first considered as infrequent, they in fact seem to affect (to some extent) more than half of patients. The symptoms are mainly manifested by anorexia, diarrhea, nausea and/or vomiting and abdominal pain. Even though prognosis is associated with lung injury, digestive symptoms seem significantly more frequent in patients presenting with severe COVID-19 infection. Digestive forms, which may be isolated or which can precede pulmonary symptoms, have indeed been reported, with diarrhea as a leading clinical sign. The main biological abnormalities that can suggest COVID-19 infection at an early stage are lymphopenia, elevated CRP and heightened ASAT transaminases. Thoraco-abdominal scan seems useful as a means of on the one hand ruling out digestive pathology not connected with coronavirus and on the other hand searching for pulmonary images compatible with COVID-19 infection. No data exist on the interest of digestive endoscopy in cases of persistent digestive symptoms. Moreover, the endoscopic surgeons may themselves be at significant risk of contamination. Fecal-oral transmission of the infection is possible, especially insofar as viral shedding in stools seems frequent and of longer duration than at the ENT level, including in patients with negative throat swab and without digestive symptoms. In some doubtful cases, virologic assessment of stool samples can yield definitive diagnosis. In the event of prolonged viral shedding in stools, a patient’s persistent contagiousness is conceivable but not conclusively established. Upcoming serology should enable identification of the patients having been infected by the COVID-19 epidemic, particularly among previously undetected pauci-symptomatic members of a health care staff. Resumption of medico-surgical activity should be the object of a dedicated strategy preceding deconfinement.
has issue date	2020-04-24(xsd:dateTime)
bibo:doi	10.1016/j.jviscsurg.2020.04.017
bibo:pmid	32360205
has license	els-covid
sha1sum (hex)	d3a1699f0d287bdf87132875b16c53a56a8d9d5d
schema:url	https://doi.org/10.1016/j.jviscsurg.2020.04.017
resource representing a document's title	What do surgeons need to know about the digestive disorders and paraclinical abnormalities induced by COVID-19?
has PubMed Central identifier	PMC7181975
has PubMed identifier	32360205
schema:publication	J Visc Surg
resource representing a document's body	covid:d3a1699f0d287bdf87132875b16c53a56a8d9d5d#body_text
is schema:about of	named entity 'ENT' named entity 'ASSESSMENT' named entity 'PATIENTS' named entity 'NO DATA' named entity 'ELEVATED CRP' named entity 'BUT' named entity 'HEALTH CARE' named entity 'COMPOSED OF' named entity 'SIGNIFICANT' named entity 'FORMS' named entity 'LYMPHOPENIA' named entity 'LEVEL' named entity 'THROAT SWAB' named entity 'diarrhea' named entity 'COVID' named entity 'endoscopy' named entity 'diarrhea' named entity 'Thoraco' named entity 'Fecal-oral transmission' named entity 'nausea' named entity 'COVID' named entity 'ENT' named entity 'virologic' named entity 'anorexia' named entity 'serology' named entity 'stool analysis' named entity 'diarrhea' named entity 'Inflammatory Bowel Diseases' named entity 'viremia' named entity 'receptor' named entity 'palliative' named entity 'diarrhea' named entity 'comorbidities' named entity 'MERS-CoV' named entity 'ACE2' named entity 'chemotherapy' named entity 'epidemics' named entity 'respiratory insufficiency' named entity 'COVID-19' named entity 'vomiting' named entity 'COVID' named entity 'fistula' named entity 'COVID' named entity 'metastatic' named entity 'infection' named entity 'COVID' named entity 'colonoscopy' named entity 'Coronaviruses' named entity 'necrosectomy' named entity 'antibiotic treatment' named entity 'blood donations' named entity 'diarrhea' named entity 'RT-PCR' named entity 'Wuhan' named entity 'disinfectant' named entity 'infection' named entity 'ileum' named entity 'pneumopathy' named entity 'asthenia' named entity 'diarrhea' named entity 'COVID' named entity 'endoscopy' named entity 'small intestine' named entity 'saliva' named entity 'ACE2' named entity 'Middle East' named entity 'hypoxemia' named entity 'immunomodulatory' named entity 'fever' named entity 'lungs' named entity 'chemotherapy' named entity 'coronavirus' named entity 'virus' named entity 'diarrhea' named entity 'chemotherapy' named entity 'serine protease'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software